How much do cancer-related symptoms contribute to health-related quality of life in lung and colorectal cancer patients? A report from the Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium
- PMID: 25891437
- PMCID: PMC4529790
- DOI: 10.1002/cncr.29415
How much do cancer-related symptoms contribute to health-related quality of life in lung and colorectal cancer patients? A report from the Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium
Abstract
Background: The objective of this study was to examine associations of symptoms with physical and mental health-related quality of life (HRQOL) in patients with colorectal cancer (CRC) and in patients with lung cancer.
Methods: Patients with newly diagnosed CRC (n = 3040) or lung cancer (n = 2297) who were participating in the Cancer Care Outcomes Research and Surveillance Consortium study completed surveys on general HRQOL and symptoms. HRQOL was measured by using physical component summary (PCS) and mental component summary (MCS) scores on the Medical Outcomes Study 12-item short-form heath survey. Nonspecific cancer symptoms were measured using items from the European Organization for Research and Treatment of Cancer core quality-of-life questionnaire. Cancer type-specific modules developed by the European Organization for Research and Treatment of Cancer were used to assess CRC-specific and lung cancer-specific symptoms. For both cancer types, linear regression models that were controlled for demographic and clinical information were used to examine correlations of nonspecific and cancer-specific symptoms with PCS and MCS scores.
Results: PCS scores for patients with CRC and lung cancer were below the general population norm of 50 (43 and 37, respectively), and MCS scores were at the population norm. For the CRC sample, in the model that included both symptom indices, an increase in nonspecific symptoms was more strongly associated with lower PCS and MCS scores than an increase in CRC-specific symptoms (PCS, standardized coefficient [β] = -0.41 vs -0.09; MCS, β = -0.38 vs -0.08). In a similar model for lung cancer, increases in lung cancer-specific symptoms were more strongly associated with lower PCS scores (β = -0.34 vs -0.20), whereas nonspecific symptoms were more strongly associated with lower MCS scores (β = -0.34 vs -0.14).
Conclusions: Symptoms were associated with HRQOL impairments in recently diagnosed patients. Additional supportive care implemented early in cancer care, regardless of cancer stage, may provide symptom relief and improve HRQOL.
Keywords: cancer; colorectal; health-related quality of life; lung; symptoms.
© 2015 American Cancer Society.
Conflict of interest statement
All authors confirm that they have no financial disclosures to report and no conflicts of interest.
References
-
- American Cancer Society. Cancer facts & figures 2014. Atlanta: American Cancer Society; 2014.
-
- Efficace F, Bottomley A, Vanvoorden V, Blazeby JM. Methodological issues in assessing health-related quality of life of colorectal cancer patients in randomised controlled trials. Eur J Cancer. 2004;40(2):187–197. - PubMed
-
- Bottomley A, Efficace F, Thomas R, Vanvoorden V, Ahmedzai SH. Health-related quality of life in Non–Small-cell lung cancer: Methodologic issues in randomized controlled trials. J Clin Oncol. 2003;21(15):2982–2992. - PubMed
-
- Institute of Medicine. Delivering high-quality cancer care: Charting a new course for a system in crisis. Washington, DC: National Academies Press; 2013. - PubMed
Publication types
MeSH terms
Grants and funding
- P30AG021684/AG/NIA NIH HHS/United States
- U01 CA093329/CA/NCI NIH HHS/United States
- U01 CA093348/CA/NCI NIH HHS/United States
- U01 CA093324/CA/NCI NIH HHS/United States
- T32 HS013852/HS/AHRQ HHS/United States
- P20 MD000182/MD/NIMHD NIH HHS/United States
- P30 AG021684/AG/NIA NIH HHS/United States
- U01 CA093326/CA/NCI NIH HHS/United States
- U01 CA093332/CA/NCI NIH HHS/United States
- 2P20MD000182/MD/NIMHD NIH HHS/United States
- U01 CA093339/CA/NCI NIH HHS/United States
- K12 HS023009/HS/AHRQ HHS/United States
- HS013852-07/HS/AHRQ HHS/United States
- U01 CA093344/CA/NCI NIH HHS/United States
- U01 CA01013/CA/NCI NIH HHS/United States
- U01 CDA093344/PHS HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
